$PODD News

Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference Transcript

How The Insulet (PODD) Investment Narrative Is Evolving After Recent Developments

Insulet Announces US Rollout Of New Algorithm Enhancements For Omnipod 5 Automated Insulin Delivery System

Insulet Corporation (PODD) Initiates Voluntary Correction For Certain Omnipod Devices

Court overturns Insulet’s $59M trade secret verdict against EOFlow

Insulet Device Correction Puts Omnipod Safety And Valuation In Focus

Citigroup Maintains Neutral on Insulet, Lowers Price Target to $165

William Blair Initiates on Insulet (PODD) With Outperform and Says the Valuation Gap Is Hard to Justify

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

PODD and Omnipod 5: What's Driving Insulet's 2026 Growth

Insulet recalls 7M patch pumps due to leak risk

RBC Capital Reiterates Outperform on Insulet, Maintains $280 Price Target

BTIG Maintains Buy on Insulet, Lowers Price Target to $235

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

Insulet Announces Voluntary Medical Device Correction For Specific Lots Of Omnipod 5, Omnipod DASH, And Omnipod Insulin Management System Pods Due To Manufacturing Issue

Beta Bionics to launch its first insulin patch pump to compete with Insulet

Are Wall Street Analysts Bullish on Insulet Stock?

Here’s Insiders Fund’s Thesis on Insulet Corporation (PODD)

A Look At Insulet (PODD) Valuation After A Sharp Share Price Pullback

B of A Securities Maintains Buy on Insulet, Lowers Price Target to $208